Chemed Corporation (NYSE: CHE) reported Q4 EPS of $5.39, $0.08 better than the analyst estimate of $5.31. Revenue for the quarter came in at $547 million versus the consensus estimate of $546.6 million.

GUIDANCE:

Chemed Corporation sees FY2023 EPS of $20.75-$21.10, versus the consensus of $20.21.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.